After years of promise, gene editing is increasingly becoming a real medical technology rather than a laboratory experiment.
Researchers are advancing next-generation CRISPR systems, base editing and precision genetic therapies capable of correcting inherited diseases at their source. Experts say the major challenge is no longer editing DNA, but safely delivering those edits into the human body.
The field is moving rapidly toward treatments that could permanently cure genetic disorders previously considered untreatable.
